Business

'Best Technology 2009' Award

'Best Technology 2009' Award.

articleImmupharma PlcOctober 19, 20093/company/immupharma-plc/news/best-technology-2009-award
'Best Technology 2009' Award

About this update from Immupharma Plc

[{"type":"text","content":"\n RNS Number : 9985A Immupharma PLC 19 October 2009  \n \n\n\n\n\n\n\nFOR IMMEDIATE RELEASE\n\n\n19 OCTOBER 2009\n\n\n\n\n\n\n \n\nImmuPharma PLC\n\n(\"ImmuPharma\")\n\nImmuPharma wins 'Best Technology 2009' Award at the AIM Awards\n\nImmuPharma PLC (LSE: IMM) the specialist discovery and development pharmaceutical company, has won the Best Technology Award at the AIM Awards 2009, organized by the London Stock Exchange. \n\nThe Award, announced at the AIM Awards Dinner in London on 15 October 2009, is presented to the company which reflects the innovation and entrepreneurial skills that are considered the cornerstone of the AIM culture.\n\nCommenting on the award, Richard Warr, Chairman of ImmuPharma said: \"ImmuPharma is honoured to receive the Best Technology Award at the 2009 AIM Awards Dinner. It is a prestigious award and I should like to thank the AIM community for recognising the innovation and entrepreneurial skills that have driven ImmuPharma forward over the last few years. This Award builds on our success at the European Mediscience Awards in June 2009 where ImmuPharma was awarded the Breakthrough of the Year Award. For ImmuPharma the journey is very much beginning and to have received such public recognition over the past year is particularly rewarding.\"\n\n- Ends -\n\nFor further information please contact: \n\n\n\n\n\nImmuPharma PLC\n\n\n+44 20 7152 4080\n\n\n\n\nDimitri Dimitriou, Chief Executive Officer \nRichard Warr, Chairman\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBuchanan Communications\n\n\n+44 20 7466 5000\n\n\n\n\nLisa Baderoon \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nPanmure Gordon & Co                     \nAndrew Burnett\nRakesh Sharma\n\n\n+44 151 243 0963\n\n\n\n\n\n\n\n\n\n\n\n\nNoble & Company Limited\n\n\n+44 20 7763 2200\n\n\n\n\nJames Bromhead\nSam Reynolds\n\n\n\n\n\n\n\n\n\nNotes to Editors\n\nAbout ImmuPharma PLC\n\nImmuPharma is a drug discovery and development group with its key operations in London an...

More updates from Immupharma Plc